OrphAI Therapeutics

New Haven, CT · Founded 2013 · Privately Held (backing)

Developer of a precision therapeutics technology designed to treat cancer and rare diseases. OrphAI Therapeutics is based in New Haven, CT and was founded in 2013. Its last known valuation is $300 million. It has raised $155 million.

Last price · $/share

—

Implied valuation

$300.0M

Total raised

$154.5M

Last round

—

How much has OrphAI Therapeutics raised?

$154.5Macross 0 recorded rounds

Free account

More of OrphAI Therapeutics with a free account

·Watch OrphAI Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

OrphAI Therapeutics investors

7 investors are on record for OrphAI Therapeutics, including YuanBio Venture Capital, Yonghua Capital, 4Catalyzer and Albany Capital (Australia).

For fundraisers

Raising for a company like OrphAI Therapeutics?

7 investors have backed OrphAI Therapeutics.

See all 7 investors →

Frequently asked about OrphAI Therapeutics

How much has OrphAI Therapeutics raised?: OrphAI Therapeutics has raised $154.5M in total across 0 recorded funding rounds.